AI
20/20 Biolabs Inc.
AIDX · NASDAQ
$0.47 +0.21% (+$0.00)
1M -9.20%
Market Cap $5.76M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.65
38.2% upside
Trenutna cena
$0.47
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica AIDX trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
61 /100
Fair P/S 2.82x
P/FFO N/A
P/B N/A
Growth
0 /100
Declining Rev. growth 43.03%
FCF growth N/A
Book val. growth N/A
Profitability
11 /100
Weak Net margin 182.82%
Op. margin 162.87%
FCF margin 93,867.70%
Quality
2 /100
Poor ROA 0.09%
Asset turnover 0.00x
ROIC 0.26%
Debt
5 /100
High Int. coverage 0.02x
Current ratio 0.60x
Net debt/EBITDA N/A
Stability
8 /100
Unstable Rev. volatility 61.85%
EPS volatility 412.29%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o AIDX
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Jonathan Cohen
Employees
14
Headquarters
Gaithersburg